Kangqian Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kangqian Lin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Heng Guo
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, China
2 shared publications - Miao Cao
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, China
2 shared publications - Tongtong Xu
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, China
2 shared publications - Yizhong Yan
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, Xinjiang, China
2 shared publications - Yunhua Hu
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, Xinjiang, China
2 shared publications - Chenxian Dong
Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, Xinjiang, China; Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, China; Key Laboratory of Preventive Medicine, Shihezi University, Shihezi, Xinjiang, China
1 shared publication
Latest Publications
- Open Access
- 11 September 2025
- Published by Springer Nature in Research Square
Trend and burden of Alzheimer's disease and other dementias in China 1990–2021: a systematic analysis with forecasts to 2035
Background: Alzheimer's Disease (AD) has become a major public health problem affecting the health of the elderly as the global population ages. This study aims to analyze the epidemiological characteristics of AD in China, predict its future trends, and explore coping strategies, with the aim of providing a scientific basis for public health policy making. Methods: Using data from the Global Burden of Disease Study 2021, this study assessed the underlying prevalence characteristics and trends in AD age-standardized incidence and mortality using a combination of joint point regression models and (Bayesian) age-period-cohort models. Results: The age-standardized incidence and mortality of AD and other dementias in China in 2021 were 151.47 /100 000 and 30.82/10 000, and the age-standardized rate of disability-adjusted life year was 562.39 /100 000. Between 1990 and 2021, the age-standardized incidence showed an increasing trend, while the age-standardized mortality declined slightly. Age is a significant risk factor for incidence and mortality in AD and other dementias, with both incidence and mortality increasing significantly with age. Period and cohort effects showed fluctuations in incidence and mortality across time and cohorts. Projection analyses suggest that the standardized incidence and mortality for AD and other dementias will increase steadily between 2022 and 2035. Conclusion: The age-standardized incidence and mortality for AD and other dementias increase significantly with age and are higher for female than for male. Despite a slight decline in mortality in recent years, the age-standardized incidence is still rising and is projected to continue to increase over the next 10 years. Suggesting that the burden of the disease on the public health system may further increase, there is an urgent need to strengthen early screening, diagnosis and interventions to cope with the growing disease burden in the future.
- 11 September 2025
- Published by Springer Nature in Research Square
Open AccessTrend and burden of Alzheimer's disease and other dementias in China 1990–2021: a systematic analysis with forecasts to 2035
Background: Alzheimer's Disease (AD) has become a major public health problem affecting the health of the elderly as the global population ages. This study aims to analyze the epidemiological characteristics of AD in China, predict its future trends, and explore coping strategies, with the aim of providing a scientific basis for public health policy making. Methods: Using data from the Global Burden of Disease Study 2021, this study assessed the underlying prevalence characteristics and trends in AD age-standardized incidence and mortality using a combination of joint point regression models and (Bayesian) age-period-cohort models. Results: The age-standardized incidence and mortality of AD and other dementias in China in 2021 were 151.47 /100 000 and 30.82/10 000, and the age-standardized rate of disability-adjusted life year was 562.39 /100 000. Between 1990 and 2021, the age-standardized incidence showed an increasing trend, while the age-standardized mortality declined slightly. Age is a significant risk factor for incidence and mortality in AD and other dementias, with both incidence and mortality increasing significantly with age. Period and cohort effects showed fluctuations in incidence and mortality across time and cohorts. Projection analyses suggest that the standardized incidence and mortality for AD and other dementias will increase steadily between 2022 and 2035. Conclusion: The age-standardized incidence and mortality for AD and other dementias increase significantly with age and are higher for female than for male. Despite a slight decline in mortality in recent years, the age-standardized incidence is still rising and is projected to continue to increase over the next 10 years. Suggesting that the burden of the disease on the public health system may further increase, there is an urgent need to strengthen early screening, diagnosis and interventions to cope with the growing disease burden in the future.
- Open Access
- 28 August 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-12
Epidemiological characteristics of leukemia in China, 2005–2017: a log-linear regression and age-period-cohort analysis
Background: Leukemia is a threat to human health, and there are relatively few studies on the incidence, mortality and disease burden analysis of leukemia in China. This study aimed to analyze the incidence and mortality rates of leukemia in China from 2005 to 2017 and estimate their age-period-cohort effects, it is an important prerequisite for effective prevention and control of leukemia. Methods: Leukemia incidence and mortality data from 2005 to 2017 were collected from the Chinese Cancer Registry Annual Report. Joinpoint regression model was used to estimate the average annual percentage change (AAPC) and annual percentage change (APC) response time trend. Age-period-cohort model was constructed to analyze the effects of age, period and cohort. Results: The age-standardized incidence rate of leukemia was 4.54/100,000 from 2005 to 2017, showed an increasing trend with AAPC of 1.9% (95% CI: 1.3%, 2.5%). The age-standardized mortality rate was 2.91/100,000, showed an increasing trend from 2005 to 2012 with APC of 2.1% (95%CI: 0.4%, 3.9%) and then a decreasing trend from 2012 to 2017 with APC of -2.5% (95%CI: -5.3%, 0.3%). The age-standardized incidence (mortality) rates of leukemia were not only higher in males than that in females, but also increased more rapidly. The incidence of leukemia in rural areas was lower than in urban areas, but the AAPC was 2.2 times higher than urban areas. Children aged 0–4 years were at higher risk of leukemia. The risk of leukemia incidence and mortality increased with age. The period effect of leukemia mortality risk showed a decreasing trend, while the cohort effect showed an increasing and then decreasing trend with the turning point of 1955–1959. Conclusions: The age-standardized incidence rate of leukemia in China showed an increasing trend from 2005 to 2017, while the age-standardized mortality rate increased first and then decreased in 2012 as a turning point. Differences existed by gender and region. The risk of leukemia incidence and mortality increased accordingly with age. The risk of mortality due to leukemia gradually decreased from 2005 to 2017. Leukemia remains a public health problem that requires continuous attention.
- 28 August 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-12
Open AccessEpidemiological characteristics of leukemia in China, 2005–2017: a log-linear regression and age-period-cohort analysis
Background: Leukemia is a threat to human health, and there are relatively few studies on the incidence, mortality and disease burden analysis of leukemia in China. This study aimed to analyze the incidence and mortality rates of leukemia in China from 2005 to 2017 and estimate their age-period-cohort effects, it is an important prerequisite for effective prevention and control of leukemia. Methods: Leukemia incidence and mortality data from 2005 to 2017 were collected from the Chinese Cancer Registry Annual Report. Joinpoint regression model was used to estimate the average annual percentage change (AAPC) and annual percentage change (APC) response time trend. Age-period-cohort model was constructed to analyze the effects of age, period and cohort. Results: The age-standardized incidence rate of leukemia was 4.54/100,000 from 2005 to 2017, showed an increasing trend with AAPC of 1.9% (95% CI: 1.3%, 2.5%). The age-standardized mortality rate was 2.91/100,000, showed an increasing trend from 2005 to 2012 with APC of 2.1% (95%CI: 0.4%, 3.9%) and then a decreasing trend from 2012 to 2017 with APC of -2.5% (95%CI: -5.3%, 0.3%). The age-standardized incidence (mortality) rates of leukemia were not only higher in males than that in females, but also increased more rapidly. The incidence of leukemia in rural areas was lower than in urban areas, but the AAPC was 2.2 times higher than urban areas. Children aged 0–4 years were at higher risk of leukemia. The risk of leukemia incidence and mortality increased with age. The period effect of leukemia mortality risk showed a decreasing trend, while the cohort effect showed an increasing and then decreasing trend with the turning point of 1955–1959. Conclusions: The age-standardized incidence rate of leukemia in China showed an increasing trend from 2005 to 2017, while the age-standardized mortality rate increased first and then decreased in 2012 as a turning point. Differences existed by gender and region. The risk of leukemia incidence and mortality increased accordingly with age. The risk of mortality due to leukemia gradually decreased from 2005 to 2017. Leukemia remains a public health problem that requires continuous attention.
- Open Access
- 12 June 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-14
Patterns of global burden of 13 diseases attributable to lead exposure, 1990–2019
Objectives: Understanding the spatio-temporal patterns of the global burden of various diseases resulting from lead exposure is critical for controlling lead pollution and disease prevention. Methods: Based on the 2019 Global Burden of Disease (GBD) framework and methodology, the global, regional, and national burden of 13 level-three diseases attributable to lead exposure were analyzed by disease type, patient age and sex, and year of occurrence. Population attributable fraction (PAF), deaths and disability-adjusted life years (DALYs), age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) obtained from the GBD 2019 database were used as descriptive indicators, and the average annual percentage change (AAPC) was estimated by a log-linear regression model to reflect the time trend. Results and conclusions: From 1990 to 2019, the number of deaths and DALYs resulting from lead exposure increased by 70.19% and 35.26%, respectively; however, the ASMR and ASDR decreased by 20.66% and 29.23%, respectively. Ischemic heart disease (IHD), stroke, and hypertensive heart disease (HHD) showed the highest increases in deaths; IHD, stroke, and diabetes and kidney disease (DKD) had the fastest-growing DALYs. The fastest decline in ASMR and ASDR was seen in stroke, with AAPCs of -1.25 (95% CI [95% confidence interval]: -1.36, -1.14) and -1.66 (95% CI: -1.76, -1.57), respectively. High PAFs occurred mainly in South Asia, East Asia, the Middle East, and North Africa. Age-specific PAFs of DKD resulting from lead exposure were positively correlated with age, whereas the opposite was true for mental disorders (MD), with the burden of lead-induced MD concentrated in children aged 0–6 years. The AAPCs of ASMR and ASDR showed a strong negative correlation with the socio-demographic index. Our findings showed that the global impact of lead exposure and its burden increased from 1990 to 2019 and varied significantly according to age, sex, region, and resulting disease. Effective public health measures and policies should be adopted to prevent and control lead exposure.
- 12 June 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-14
Open AccessPatterns of global burden of 13 diseases attributable to lead exposure, 1990–2019
Objectives: Understanding the spatio-temporal patterns of the global burden of various diseases resulting from lead exposure is critical for controlling lead pollution and disease prevention. Methods: Based on the 2019 Global Burden of Disease (GBD) framework and methodology, the global, regional, and national burden of 13 level-three diseases attributable to lead exposure were analyzed by disease type, patient age and sex, and year of occurrence. Population attributable fraction (PAF), deaths and disability-adjusted life years (DALYs), age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) obtained from the GBD 2019 database were used as descriptive indicators, and the average annual percentage change (AAPC) was estimated by a log-linear regression model to reflect the time trend. Results and conclusions: From 1990 to 2019, the number of deaths and DALYs resulting from lead exposure increased by 70.19% and 35.26%, respectively; however, the ASMR and ASDR decreased by 20.66% and 29.23%, respectively. Ischemic heart disease (IHD), stroke, and hypertensive heart disease (HHD) showed the highest increases in deaths; IHD, stroke, and diabetes and kidney disease (DKD) had the fastest-growing DALYs. The fastest decline in ASMR and ASDR was seen in stroke, with AAPCs of -1.25 (95% CI [95% confidence interval]: -1.36, -1.14) and -1.66 (95% CI: -1.76, -1.57), respectively. High PAFs occurred mainly in South Asia, East Asia, the Middle East, and North Africa. Age-specific PAFs of DKD resulting from lead exposure were positively correlated with age, whereas the opposite was true for mental disorders (MD), with the burden of lead-induced MD concentrated in children aged 0–6 years. The AAPCs of ASMR and ASDR showed a strong negative correlation with the socio-demographic index. Our findings showed that the global impact of lead exposure and its burden increased from 1990 to 2019 and varied significantly according to age, sex, region, and resulting disease. Effective public health measures and policies should be adopted to prevent and control lead exposure.